Noninvasive bioengineering assessment of psoriasis

E. Berardesca, H. I. Maibach

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Most of this investigation deals with descriptive phenomena; we now have a partial profile of the biophysical events in psoriasis, as well as their expected return toward normality with successful pharmacologic therapy. What we clearly need is use of this database to develop therapeutic interventions that are valuable to the psoriatic. What might be reasonably accomplished? Although many possibilities exist, one practical approach would document the returning of the parameter investigated to normal, possibly predictive of a therapeutic result. Currently we wait at least 1 week before altering a therapeutic regimen based on lesion morphology and patient preference. It is possible that a biophysical signal of skin function might predict management change in days rather than weeks. Lesion blood flow after treatment plummets towards normality in about 48 hours. Should we monitor lesion blood flow at this time to seek predictions of eventual efficacy? In a chronic and discomforting disease like psoriasis, a rational approach of this type surely deserves attention.

Original languageEnglish
Pages (from-to)157-160
Number of pages4
JournalInternational Journal of Dermatology
Volume28
Issue number3
Publication statusPublished - 1989

Fingerprint

Bioengineering
Psoriasis
Patient Preference
Therapeutics
Chronic Disease
Databases
Skin

ASJC Scopus subject areas

  • Dermatology

Cite this

Berardesca, E., & Maibach, H. I. (1989). Noninvasive bioengineering assessment of psoriasis. International Journal of Dermatology, 28(3), 157-160.

Noninvasive bioengineering assessment of psoriasis. / Berardesca, E.; Maibach, H. I.

In: International Journal of Dermatology, Vol. 28, No. 3, 1989, p. 157-160.

Research output: Contribution to journalArticle

Berardesca, E & Maibach, HI 1989, 'Noninvasive bioengineering assessment of psoriasis', International Journal of Dermatology, vol. 28, no. 3, pp. 157-160.
Berardesca, E. ; Maibach, H. I. / Noninvasive bioengineering assessment of psoriasis. In: International Journal of Dermatology. 1989 ; Vol. 28, No. 3. pp. 157-160.
@article{f8d1279830ce40759beb1c916f4f3172,
title = "Noninvasive bioengineering assessment of psoriasis",
abstract = "Most of this investigation deals with descriptive phenomena; we now have a partial profile of the biophysical events in psoriasis, as well as their expected return toward normality with successful pharmacologic therapy. What we clearly need is use of this database to develop therapeutic interventions that are valuable to the psoriatic. What might be reasonably accomplished? Although many possibilities exist, one practical approach would document the returning of the parameter investigated to normal, possibly predictive of a therapeutic result. Currently we wait at least 1 week before altering a therapeutic regimen based on lesion morphology and patient preference. It is possible that a biophysical signal of skin function might predict management change in days rather than weeks. Lesion blood flow after treatment plummets towards normality in about 48 hours. Should we monitor lesion blood flow at this time to seek predictions of eventual efficacy? In a chronic and discomforting disease like psoriasis, a rational approach of this type surely deserves attention.",
author = "E. Berardesca and Maibach, {H. I.}",
year = "1989",
language = "English",
volume = "28",
pages = "157--160",
journal = "International Journal of Dermatology",
issn = "0011-9059",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Noninvasive bioengineering assessment of psoriasis

AU - Berardesca, E.

AU - Maibach, H. I.

PY - 1989

Y1 - 1989

N2 - Most of this investigation deals with descriptive phenomena; we now have a partial profile of the biophysical events in psoriasis, as well as their expected return toward normality with successful pharmacologic therapy. What we clearly need is use of this database to develop therapeutic interventions that are valuable to the psoriatic. What might be reasonably accomplished? Although many possibilities exist, one practical approach would document the returning of the parameter investigated to normal, possibly predictive of a therapeutic result. Currently we wait at least 1 week before altering a therapeutic regimen based on lesion morphology and patient preference. It is possible that a biophysical signal of skin function might predict management change in days rather than weeks. Lesion blood flow after treatment plummets towards normality in about 48 hours. Should we monitor lesion blood flow at this time to seek predictions of eventual efficacy? In a chronic and discomforting disease like psoriasis, a rational approach of this type surely deserves attention.

AB - Most of this investigation deals with descriptive phenomena; we now have a partial profile of the biophysical events in psoriasis, as well as their expected return toward normality with successful pharmacologic therapy. What we clearly need is use of this database to develop therapeutic interventions that are valuable to the psoriatic. What might be reasonably accomplished? Although many possibilities exist, one practical approach would document the returning of the parameter investigated to normal, possibly predictive of a therapeutic result. Currently we wait at least 1 week before altering a therapeutic regimen based on lesion morphology and patient preference. It is possible that a biophysical signal of skin function might predict management change in days rather than weeks. Lesion blood flow after treatment plummets towards normality in about 48 hours. Should we monitor lesion blood flow at this time to seek predictions of eventual efficacy? In a chronic and discomforting disease like psoriasis, a rational approach of this type surely deserves attention.

UR - http://www.scopus.com/inward/record.url?scp=0024566718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024566718&partnerID=8YFLogxK

M3 - Article

C2 - 2651335

AN - SCOPUS:0024566718

VL - 28

SP - 157

EP - 160

JO - International Journal of Dermatology

JF - International Journal of Dermatology

SN - 0011-9059

IS - 3

ER -